stockportfolio.pro
Stocks / ICLR vs PODD
ICLR vs PODD
ICON Public Limited Company and Insulet Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| ICON Public Limited Company (ICLR) | Insulet Corporation (PODD) | |
|---|---|---|
| Market cap | $11.1B | $11.1B |
| Revenue (latest FY) | $8.25B | $2.71B |
| Net income (latest FY) | $229.34M | $247.10M |
| Revenue growth (5y CAGR) | 2.1% | 24.5% |
| Net margin | 2.8% | 9.1% |
| Return on equity | 2.5% | 16.3% |
| P/E ratio | 50.0 | 37.4 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 4 | 8 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ICLR — free Open PODD — freeFrequently asked questions
Which is bigger, ICLR or PODD?
ICON Public Limited Company is larger by market capitalization — $11.1B versus $11.1B.
Which grows faster, ICLR or PODD?
Over the last five fiscal years, Insulet Corporation grew revenue faster — 24.5%/yr versus 2.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.